MUMBAI: A day after Oxford University-AstraZeneca announced that trials of its proposed Coronavirus vaccine candidate have resumed, the Serum Institute said it is awaiting further instructions from the Indian drug regulator. Clinical trials for the AstraZeneca-Oxford coronavirus vaccine resumed in the UK after the Medicines Health Regulatory Authority (MHRA) confirmed …
Read More »Serum Institute to Resume Vaccine Trials Following DCGI Approval | India News
